Acute Venous Thromboembolism
Conditions
Brief summary
The primary outcome is the rate of adjudicated clinically relevant bleeding (CRB) events defined as the composite of major bleeding (MB) events and/or clinically relevant non-major bleeding events (CRNMB).
Detailed description
a) adjudicated MB events; b) adjudicated CRNMB events; c) adjudicated recurrent VTE events; d) adjudicated VTE-related deaths; e) all-cause mortality; f) medication adherence; g) incremental cost-effectiveness ratios, including cost per one CRB case prevented, cost per one life year saved and cost per one quality-adjusted life year (QALY) gained; h) impact of verbal consent on patient participation in comparison with participants from sites using written informed consent.
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the rate of adjudicated clinically relevant bleeding (CRB) events defined as the composite of major bleeding (MB) events and/or clinically relevant non-major bleeding events (CRNMB). | — |
Secondary
| Measure | Time frame |
|---|---|
| a) adjudicated MB events; b) adjudicated CRNMB events; c) adjudicated recurrent VTE events; d) adjudicated VTE-related deaths; e) all-cause mortality; f) medication adherence; g) incremental cost-effectiveness ratios, including cost per one CRB case prevented, cost per one life year saved and cost per one quality-adjusted life year (QALY) gained; h) impact of verbal consent on patient participation in comparison with participants from sites using written informed consent. | — |
Countries
Ireland